Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Forreryd

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 29, 2018
Predicting skin sensitizers with confidence - Using conformal prediction to determine applicability domain of GARDAndy Forreryd, Ulf Norinder, Tim Lindberg, et al.
Toxics|January 28, 2026
RNA-Seq Can Be Used to Quantify Gene Expression Levels for Use in the GARDskin AssayRobin Gradin, Johan Andersson, Andy Forreryd, et al.
BMC Genomics|June 3, 2014
Evaluation of high throughput gene expression platforms using a genomic biomarker signature for prediction of skin sensitizationAndy Forreryd, Henrik Johansson, Ann-Sofie Albrekt, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 15, 2019
In vitro assessment of mechanistic events induced by structurally related chemical rubber sensitizersTim Lindberg, Andy Forreryd, Ola Bergendorff, et al.
Scientific Reports|September 24, 2021
Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskinRobin Gradin, Andy Forreryd, Ulrika Mattson, et al.
ALTEX|May 3, 2022
Exploration of the GARD™skin applicability domain: Indirectly acting haptens, hydrophobic substances and UVCBsAndy Forreryd, Robin Gradin, Charles Humfrey, et al.
ALTEX|November 7, 2022
The GARD™skin assay: Investigation of the applicability domain for metalsAndy Forreryd, Robin Gradin, Olivia Larne, et al.
Regulatory Toxicology and Pharmacology : RTP|August 9, 2019
Letter to the editor regarding the article "Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD™ (Genomic Allergen Rapid Detection) assay in comparison with OECD guideline assays alone and in combination."Andy Forreryd, Henrik Johansson, Tim Lindberg, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 18, 2016
From genome-wide arrays to tailor-made biomarker readout - Progress towards routine analysis of skin sensitizing chemicals with GARDAndy Forreryd, Kathrin S Zeller, Tim Lindberg, et al.
ALTEX|November 21, 2017
The GARD platform for potency assessment of skin sensitizing chemicalsKathrin S Zeller, Andy Forreryd, Tim Lindberg, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 29, 2018
Predicting skin sensitizers with confidence - Using conformal prediction to determine applicability domain of GARDAndy Forreryd, Ulf Norinder, Tim Lindberg, et al.
Toxics|January 28, 2026
RNA-Seq Can Be Used to Quantify Gene Expression Levels for Use in the GARDskin AssayRobin Gradin, Johan Andersson, Andy Forreryd, et al.
BMC Genomics|June 3, 2014
Evaluation of high throughput gene expression platforms using a genomic biomarker signature for prediction of skin sensitizationAndy Forreryd, Henrik Johansson, Ann-Sofie Albrekt, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 15, 2019
In vitro assessment of mechanistic events induced by structurally related chemical rubber sensitizersTim Lindberg, Andy Forreryd, Ola Bergendorff, et al.
Scientific Reports|September 24, 2021
Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskinRobin Gradin, Andy Forreryd, Ulrika Mattson, et al.
ALTEX|May 3, 2022
Exploration of the GARD™skin applicability domain: Indirectly acting haptens, hydrophobic substances and UVCBsAndy Forreryd, Robin Gradin, Charles Humfrey, et al.
ALTEX|November 7, 2022
The GARD™skin assay: Investigation of the applicability domain for metalsAndy Forreryd, Robin Gradin, Olivia Larne, et al.
Regulatory Toxicology and Pharmacology : RTP|August 9, 2019
Letter to the editor regarding the article "Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD™ (Genomic Allergen Rapid Detection) assay in comparison with OECD guideline assays alone and in combination."Andy Forreryd, Henrik Johansson, Tim Lindberg, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 18, 2016
From genome-wide arrays to tailor-made biomarker readout - Progress towards routine analysis of skin sensitizing chemicals with GARDAndy Forreryd, Kathrin S Zeller, Tim Lindberg, et al.
ALTEX|November 21, 2017
The GARD platform for potency assessment of skin sensitizing chemicalsKathrin S Zeller, Andy Forreryd, Tim Lindberg, et al.
Pageof 2